ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - RECRO PHARMA INC ownership

Back to all holdings Add to watchlist

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 78 filers reported holding RECRO PHARMA INC in Q3 2018. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Links
Filings
EDGAR links
External links
Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q2 2020$165,000
-82.8%
36,300
-30.5%
0.00%
-100.0%
Q4 2019$958,000
+711.9%
52,237
+214.7%
0.00%–
Q3 2018$118,000
+42.2%
16,6000.0%0.00%–
Q2 2018$83,000–16,600–0.00%–
 Download
Other shareholders

There were no reported owners of RECRO PHARMA INC in Q3 2018.

NameSharesValueWeighting ↓
View complete list of RECRO PHARMA INC shareholders